title: Detecting and accounting for violations of the constancy assumption in non-inferiority clinical trials.
abstract: Randomized, placebo-controlled clinical trials are the gold standard for evaluating a novel therapeutic agent. In some instances, it may not be considered ethical or desirable to complete a placebo-controlled clinical trial and, instead, the placebo is replaced by an active comparator with the objective of showing either superiority or non-inferiority to the active comparator. In a non-inferiority trial, the experimental treatment is considered non-inferior if it retains a pre-specified proportion of the effect of the active comparator as represented by the non-inferiority margin. A key assumption required for valid inference in the non-inferiority setting is the constancy assumption, which requires that the effect of the active comparator in the non-inferiority trial is consistent with the effect that was observed in previous trials. It has been shown that violations of the constancy assumption can result in a dramatic increase in the rate of incorrectly concluding non-inferiority in the presence of ineffective or even harmful treatment. In this paper, we illustrate how Bayesian hierarchical modeling can be used to facilitate multi-source smoothing of the data from the current trial with the data from historical studies, enabling direct probabilistic evaluation of the constancy assumption. We then show how this result can be used to adapt the non-inferiority margin when the constancy assumption is violated and present simulation results illustrating that our method controls the type-I error rate when the constancy assumption is violated, while retaining the power of the standard approach when the constancy assumption holds. We illustrate our adaptive procedure using a non-inferiority trial of raltegravir, an antiretroviral drug for the treatment of HIV.
authors: 1 Division of Biostatistics, School of Public Health, University of Minnesota, MN, USA.
authors: Joseph S
authors: JS
authors: Koopmeiners
authors: 2 Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors: Brian P
authors: BP
authors: Hobbs
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D001499:Bayes Theorem; D000074099:Equivalence Trials as Topic; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D016014:Linear Models; D015233:Models, Statistical; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D013223:Statistics as Topic; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents
keywords: Bayesian hierarchical modeling; HIV; Non-inferiority trial; constancy assumption; multi-source smoothing